BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Natera Reports Third Quarter 2018 Financial Results

  Natera, Inc. today reported financial results for the third quarter ended September 30, 2018, and provided an update on recent business progress.

  November 8, 2018

   · 

  14 min read
• Deals

  Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) on November 6, 2018

  Endologix, Inc. announced today the grant of inducement equity awards to three newly hired employees (together, the “Awardees”).

  November 8, 2018

   · 

  1 min read
• Business

  Aurinia Reports Third Quarter 2018 Financial Results, Clinical Highlights and Corporate Development

  AURORA Phase III Trial in lupus nephritis completes enrollment ahead of schedule

  November 8, 2018

   · 

  16 min read
• Business

  Aimmune Therapeutics Announces Third Quarter 2018 Financial Results and Recent Corporate Highlights

  Recently completed Phase 3 RAMSES study confirms safety profile of AR101 in peanut-allergic children and teens

  November 8, 2018

   · 

  10 min read
• Business

  Omeros Corporation Reports Third Quarter 2018 Financial Results

  Conference Call Friday, November 9th at 8:30 a.m. ET

  November 8, 2018

   · 

  15 min read
• Business

  AmpliPhi Biosciences Reports Third Quarter 2018 Financial Results and Business Highlights

  The company intends to initiate one or more clinical trials in 2019 following positive FDA feedback

  November 8, 2018

   · 

  10 min read
• Business

  Tricida Announces Third Quarter 2018 Financial Results

  Advanced Key Initiatives for NDA Submission

  November 8, 2018

   · 

  10 min read
• Business

  Senseonics Holdings, Inc. Reports Third Quarter 2018 Financial Results

  Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today reported financial results for the third quarter ended September 30, 2018.

  November 8, 2018

   · 

  8 min read
• Genetown

  Ironwood Pharmaceuticals to Present at 27th Annual Credit Suisse Healthcare Conference

  Ironwood Pharmaceuticals Inc. will present a corporate update at the 27th Annual Credit Suisse Healthcare Conference on Wednesday, November 14th, 2018 at 2:15 p.m.

  November 8, 2018

   · 

  2 min read
• Business

  Hanger Announces Financial Results for the Third Quarter of 2018

  Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, today announced its financial results for the third quarter ended September 30, 2018.

  November 8, 2018

   · 

  25 min read